Control of important helminthic infections vaccine development as part of the solution.
Among the tools available for the control of helminth infections, chemotherapy has come to totally dominate the field. In the veterinary field, development of drug resistance has appeared but this is not (yet) a problem in the control of human diseases. Although there is no vaccine commercially available for any human parasitic infection yet, recent progress in vaccine development is making this a future possibility for several diseases. The goal of chemotherapy is to alleviate infection and morbidity in the definitive host, or reduce transmission, while the effect of available vaccine candidates would mainly be to influence transmission through targeting the intermediate or reservoir host, when the infection is zoonotic. Apart from this general scheme, there are also vaccine candidates targeting the parasites in the definitive host, in particular the early developmental stages, which should reduce the risk of drug failure. Since the biological targets in most cases are different, vaccination would be synergistic with drug therapy. This review covers diseases caused by helminthes in both humans and animals and includes examples of diseases caused by cestodes, nematodes and trematodes. The focus is on infections for which vaccine development has been undertaken for a long time, resulting in products that could realistically become integrated into control strategies in the near future.
Bergquist
Robert
R
Ingerod, Brastad, Sweden.
Lustigman
Sara
S
D000818:Animals; D002589:Cestoda / Q000276:immunology; D006373:Helminthiasis / Q000276:immunology / Q000517:prevention & control*; D006374:Helminthiasis, Animal / Q000276:immunology / Q000517:prevention & control*; D006801:Humans; D009348:Nematoda / Q000276:immunology; D014200:Trematoda / Q000276:immunology; D014612:Vaccines / Q000276:immunology*
D014612:Vaccines